92 related articles for article (PubMed ID: 22677952)
1. Chemotherapy and histological stratification of biliary tract cancers.
Cariati A; Piromalli E
Oncology; 2012; 82(6):352-3. PubMed ID: 22677952
[No Abstract] [Full Text] [Related]
2. [The development of chemotherapy to unresectable advanced biliary tract cancer].
Arima S; Naruge D; Kasuga A; Kitamura H; Takasu M; Nagashima F; Furuse J
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1490-3. PubMed ID: 23133874
[No Abstract] [Full Text] [Related]
3. Cancers of the large bowel and hepatobiliary tract.
Stevenson JP; O'Dwyer PJ
Cancer Chemother Biol Response Modif; 2001; 19():547-71. PubMed ID: 11686032
[No Abstract] [Full Text] [Related]
4. [Clinical study of new chemotherapy regimen for biliary tract cancer].
Hatano E; Kanai M; Nagano H; Ioka T
Nihon Rinsho; 2015 Mar; 73 Suppl 3():805-8. PubMed ID: 25857139
[No Abstract] [Full Text] [Related]
5. [Surgical outcome of biliary tract cancer with postoperative chemotherapy].
Sugawara G; Ebata T; Yokoyama Y; Igami T; Kokuryo T; Tsunoda N; Fukaya M; Uehara K; Itatsu K; Yoshioka Y; Nagino M
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1483-5. PubMed ID: 23130375
[No Abstract] [Full Text] [Related]
6. Cancers of the large bowel and hepatobiliary tract.
Sun W; Haller D
Cancer Chemother Biol Response Modif; 2003; 21():509-34. PubMed ID: 15338761
[No Abstract] [Full Text] [Related]
7. [Surgical outcome of biliary tract cancer with neoadjuvant chemotherapy].
Kato A; Shimizu H; Yoshidome H; Otsuka M; Furukawa K; Yoshitomi H; Takeuchi D; Takayashiki T; Kuboki S; Suzuki D; Nakajima M; Miyazaki M
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1486-9. PubMed ID: 23133873
[No Abstract] [Full Text] [Related]
8. Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1.
Rajagopalan V; Daines WP; Grossbard ML; Kozuch P
Oncology (Williston Park); 2004 Jun; 18(7):889-96. PubMed ID: 15255172
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy in cancers of the gallbladder and bile ducts].
Okada S; Okazaki N
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1269-72. PubMed ID: 2069397
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
[TBL] [Abstract][Full Text] [Related]
11. Continuous hepatic arterial infusion chemotherapy for liver metastasis from biliary tract and pancreatic cancers.
Kato Y; Tsuyuki A; Kikuchi K; Tokuyama J; Kurihara N; Kumamoto Y; Fujishiro Y; Ebinuma H
Anticancer Res; 2005; 25(1B):477-82. PubMed ID: 15816615
[TBL] [Abstract][Full Text] [Related]
12. Regional chemotherapy in biliary tract cancers--a single institution experience.
Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
[TBL] [Abstract][Full Text] [Related]
13. [Development for combination of surgery and chemotherapy on biliary tract cancer].
Kato A; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Furukawa K; Yoshitomi H; Mitsuhashi N; Takeuchi D; Takayashiki T; Suda K; Takano S; Miyazaki M
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1685-89. PubMed ID: 18975457
[No Abstract] [Full Text] [Related]
14. Phase II trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperable biliary tract cancer.
Oh SY; Lee GW; Kim HG; Kim TH; Kim HJ; Kang JH
Chemotherapy; 2008; 54(6):479-84. PubMed ID: 18832821
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapy in Biliary Tract Cancers.
Merla A; Liu KG; Rajdev L
Curr Treat Options Oncol; 2015 Oct; 16(10):48. PubMed ID: 26266637
[TBL] [Abstract][Full Text] [Related]
16. Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study.
Cantore M; Fiorentini G; Mambrini A; Rabbi C; Zamagni D; Carlone N; Manni A; Caudana R; Torri T
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):59-64. PubMed ID: 16767908
[TBL] [Abstract][Full Text] [Related]
17. Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients.
Hwang IG; Jang JS; Do JH; Kang JH; Lee GW; Oh SY; Kwon HC; Jun HJ; Lim HY; Lee S; Chi KC; Lee SJ
Cancer Chemother Pharmacol; 2011 Oct; 68(4):935-44. PubMed ID: 21298384
[TBL] [Abstract][Full Text] [Related]
18. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine Extends Survival for Biliary Tract Cancer.
Cancer Discov; 2017 Jul; 7(7):OF1. PubMed ID: 28572460
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.
Lim JY; Jeung HC; Mun HS; Lee DK; Paik YH; Lee SJ; Yoon DS; Cho JY
Anticancer Drugs; 2008 Jul; 19(6):631-5. PubMed ID: 18525323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
